RELMADA THERAPEUTICS, INC. Taxes and Licenses
RELMADA THERAPEUTICS, INC. (RLMD) reported Taxes and Licenses of $45.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Notes
us-gaap:TaxesAndLicenses · last filed 2025-05-12
- RELMADA THERAPEUTICS, INC. taxes and licenses for the quarter ending 2025-03-31 was $45.00K, a 0.00% change year-over-year.
- RELMADA THERAPEUTICS, INC. taxes and licenses for the quarter ending 2024-12-31 was $0.00.
- RELMADA THERAPEUTICS, INC. taxes and licenses for the quarter ending 2024-09-30 was $0.00.
- RELMADA THERAPEUTICS, INC. taxes and licenses for the quarter ending 2024-06-30 was $0.00.
- RELMADA THERAPEUTICS, INC. taxes and licenses for fiscal 2024 was $45.00K, a 0.00% change from fiscal 2023.
- RELMADA THERAPEUTICS, INC. taxes and licenses for fiscal 2023 was $45.00K.
| Period end | Taxes and Licenses 3 month | Taxes and Licenses 6 month | Taxes and Licenses 9 month | Taxes and Licenses 12 month |
|---|---|---|---|---|
| 2025-03-31 | $45.00K 10-Q · filed 2025-05-12 | $45.00K derived: sum of 2 quarters · filed 2025-05-12 | $45.00K derived: sum of 3 quarters · filed 2025-05-12 | $45.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 derived: sum of 3 quarters · filed 2025-03-27 | $45.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $45.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $45.00K 10-Q · filed 2024-08-07 | ||
| 2024-03-31 | $45.00K 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $45.00K 10-K · filed 2024-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |